New drug combo shows promise for Hard-to-Treat cancers
Disease control
Recruiting now
This study tests a new drug called GI-101, alone or with other cancer drugs (pembrolizumab or lenvatinib), in people with advanced solid tumors that have spread. The goal is to see if it is safe and helps control the cancer. About 317 adults with certain cancers like lung, kidney…
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC